| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 2.380 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | - | - | - | 0 | 2.380 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | - | - | - | - | 97 | 3.322 | 4.563 | 3.581 | 2.523 | 6 |
| Gross Profit/Loss - EUR | - | - | - | - | -97 | -942 | -4.563 | -3.581 | -2.523 | -6 |
| Net Profit/Loss - EUR | - | - | - | - | -97 | -966 | -4.563 | -3.581 | -2.523 | -6 |
| Employees | - | - | - | - | 0 | 2 | 2 | 1 | 1 | 0 |
Check the financial reports for the company - Biolife Banat S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | 872 | 1.268 | 4 | 13 | -19 | 578 |
| Inventories | - | - | - | - | 792 | 828 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 401 | 0 | 0 | 0 | 0 |
| Cash | - | - | - | - | 80 | 39 | 4 | 13 | -19 | 578 |
| Shareholders Funds | - | - | - | - | -55 | -1.020 | -5.560 | -9.158 | -11.654 | -11.595 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 927 | 2.288 | 5.563 | 9.171 | 11.635 | 12.173 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9329 - 9329" | |||||||||
| CAEN Financial Year |
1039
|
|||||||||
Comments - Biolife Banat S.r.l.